Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jun;28(3):115-25.
doi: 10.1023/b:ifla.0000039557.33267.65.

Murine model for non-IgE-mediated asthma

Affiliations
Comparative Study

Murine model for non-IgE-mediated asthma

Hanneke P M van der Kleij et al. Inflammation. 2004 Jun.

Abstract

There is increasing evidence that inflammatory mechanisms other than atopy or eosinophilic inflammation may be involved in the pathogenesis of asthma. The mechanisms associated with non-atopic (non-IgE) or neutrophil-mediated asthma are poorly investigated. Non-atopic airway inflammation and hyperresponsiveness was induced in mice by skin sensitization with dinitrofluorobenzene (DNFB) followed by intra-airway challenge with dinitrobenzene sulfonic acid (DNS). Acute bronchoconstriction and mast cell activation were observed shortly after challenge. Increased levels of the major mast cell mediator, TNF-alpha, were found in the bronchoalveolar lavage fluid of DNFB-sensitized. Mast cells play a key role in the early release of TNF-alpha since mast-cell-deficient WBB6F1-W/Wv mice did not show an increase in TNF-alpha release after DNFB-sensitization and DNS challenge compared to their ++ littermates. Features of the late-phase pulmonary reaction included mononuclear and neutrophilic cell infiltration, pulmonary edema, in vitro tracheal hyperreactivity and in vivo airway hyperresponsiveness. These characteristics bear marked similarity with those observed in non-atopic asthmatic patients. Therefore, this model can be used to further study the mechanisms potentially responsible for the development of non-IgE-mediated asthma.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int Arch Allergy Appl Immunol. 1983;72(1):59-66 - PubMed
    1. J Immunol. 1994 Nov 1;153(9):4169-78 - PubMed
    1. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):858-65 - PubMed
    1. J Immunol. 1996 Aug 15;157(4):1625-9 - PubMed
    1. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):766-75 - PubMed

Publication types